ReviewFrontiers in oncology2024

Our current understanding of the biological impact of endometrial cancer mtDNA genome mutations and their potential use as a biomarker.

Pabitra Khadka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.